156 related articles for article (PubMed ID: 2969772)
1. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients.
Weizman A; Mark M; Gil-Ad I; Tyano S; Laron Z
Clin Neuropharmacol; 1988 Jun; 11(3):250-6. PubMed ID: 2969772
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of beta-endorphin, cortisol, prolactin and growth hormone in depressed patients.
Galard R; Gallart J; Arguello JM; Schwartz S; Castellanos JM; Catalán R
Acta Psychiatr Scand; 1988 Aug; 78(2):230-3. PubMed ID: 2975911
[TBL] [Abstract][Full Text] [Related]
3. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
Maes M; Jacobs MP; Suy E; Minner B; Raus J
Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
[TBL] [Abstract][Full Text] [Related]
4. The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.
Weizman A; Gil-Ad I; Grupper D; Tyano S; Laron Z
Psychopharmacology (Berl); 1987; 93(1):122-6. PubMed ID: 2957720
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine response to trihexyphenidyl in depressed patients.
Valevski A; Gil-Ad I; Modai I; Apter A; Tyano S; Laron Z; Weizman A
Clin Neuropharmacol; 1992 Feb; 15(1):27-33. PubMed ID: 1576596
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder.
Weizman R; Gil-Ad I; Hermesh H; Munitz H; Laron Z
Clin Neuropharmacol; 1990 Aug; 13(4):297-302. PubMed ID: 2208181
[TBL] [Abstract][Full Text] [Related]
7. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
Cleare AJ; Murray RM; O'Keane V
Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
[TBL] [Abstract][Full Text] [Related]
8. Hormonal responses to fenfluramine in depressed and control subjects.
Mitchell P; Smythe G
J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
[TBL] [Abstract][Full Text] [Related]
9. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B
Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
O'Keane V; Dinan TG
Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic regulation of prolactin and growth hormone secretion in man.
Lewis DA; Sherman BM
Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
[TBL] [Abstract][Full Text] [Related]
12. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
Mulder RT; Porter RJ; Joyce PR
J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
[TBL] [Abstract][Full Text] [Related]
13. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
O'Keane V; McLoughlin D; Dinan TG
J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) and prolactin responses after GH-releasing hormone in major depressive disorder: relationship to somatomedin C levels and dexamethasone suppressibility of cortisol.
Lesch KP; Laux G; Erb A; Pfüller H; Beckmann H
Psychoneuroendocrinology; 1988; 13(3):255-63. PubMed ID: 3136488
[TBL] [Abstract][Full Text] [Related]
15. HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls.
Maes M; D'Hondt P; Suy E; Minner B; Vandervorst C; Raus J
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):781-90. PubMed ID: 1662403
[TBL] [Abstract][Full Text] [Related]
16. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man.
Barbieri C; Magnoni V; Rauhe WG; Zanasi S; Caldara R; Ferrari C
Clin Endocrinol (Oxf); 1983 Dec; 19(6):705-10. PubMed ID: 6360431
[TBL] [Abstract][Full Text] [Related]
17. The effects of cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls.
Goodwin GM; Muir WJ; Seckl JR; Bennie J; Carroll S; Dick H; Fink G
J Affect Disord; 1992 Oct; 26(2):73-83. PubMed ID: 1332993
[TBL] [Abstract][Full Text] [Related]
18. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG
Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
[TBL] [Abstract][Full Text] [Related]
19. Adrenocorticotropic hormone, beta-endorphin, cortisol, growth hormone and prolactin circulating levels in nineteen athletes before and after half-marathon and marathon.
Scavo D; Barletta C; Vagiri D; Letizia C
J Sports Med Phys Fitness; 1991 Sep; 31(3):401-6. PubMed ID: 1665889
[TBL] [Abstract][Full Text] [Related]
20. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
Rajewska J; Rybakowski JK
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
